Combined Synopsis/SolicitationPosted Sep 24, 2026·Responses due Sep 28, 2026

Procurement of Sonosite LX Ultrasound System (Brand Name restriction)

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH - CC

Stage
Open solicitation
NAICS
334510
Value
Not stated
Solicitation
RFQ-26-008281
Set-aside
No Set aside used
PSC
6525
Place
Bethesda, MD, USA
Contact
Lu Chang (lu-chang.lu@nih.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation RFQ-26-008281 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 24, 2026 · this notice
    Combined Synopsis/Solicitation
Award
Not yet. Typical award: Oct 10, 2026 to Dec 16, 2026, middle of the range Oct 22, 2026.
Measured from 139 past solicitations at National Institutes of Health that later posted an award (middle half of cases, counted from Sep 24, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

Acquisition Description: This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 �Streamlined Procedures for Evaluation and solicitation for commercial Items,� as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. This acquisition will be processed under FAR Part 13 Simp… (show all)

lified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-04. The Solicitation number is RFQ-26-008281 and the solicitation is issued as a Request for Quotes (RFQ). Acquisition Description & Justification: The National Institutes of Health (NIH) Clinical Center requires the acquisition of a FUJIFILM Sonosite LX Point-of-Care Ultrasound (POCUS) System with multiple transducers to support pediatric critical care imaging. The system includes advanced diagnostic imaging capabilities, Color and Spectral Doppler, Tissue Harmonic Imaging, DICOM connectivity, wireless networking, integrated educational resources, manufacturer installation and training, and a five-year comprehensive warranty. The acquisition also includes specialty transducers to support cardiac, abdominal, pulmonary, vascular access, musculoskeletal, neonatal, and pediatric imaging applications. Justification: The Sonosite LX will provide clinicians with high-quality, real-time bedside imaging necessary for the care of critically ill pediatric patients in the Pediatric Intensive Care Unit (PICU). The system supports rapid diagnosis and ultrasound-guided procedures, including vascular access, cardiac assessments, pulmonary evaluations, abdominal imaging, and other point-of-care applications. Its portability, exceptional image quality, intuitive touchscreen workflow, advanced needle visualization technology, and comprehensive imaging capabilities enable timely clinical decision-making, improve procedural success, reduce complications, and enhance patient safety. The inclusion of multiple transducers allows a single platform to support a broad range of pediatric and critical care examinations, maximizing clinical utility while minimizing equipment redundancy. The five-year manufacturer warranty and onsite clinical training further ensure long-term reliability and successful implementation. FUJIFILM Sonosite is a recognized industry leader in point-of-care ultrasound technology with extensive experience supporting hospitals and critical care environments. The vendor offers the complete Sonosite LX platform, manufacturer-certified installation, clinical education, technical support, and a comprehensive five-year warranty for both the ultrasound system and transducers. The proposed equipment is available through an existing federal contract, ensuring compliance with federal procurement requirements while providing access to factory-authorized service, software updates, replacement components, and ongoing technical support. As the original equipment manufacturer, FUJIFILM Sonosite is uniquely qualified to provide the equipment, warranty coverage, training, and lifecycle support necessary to maintain safe and reliable operation in the NIH Clinical Center's Pediatric Intensive Care Unit. Only this specific brand of equipment from Fujitsu Sonosite can be accepted. Vendors must be authorized resellers and provide their letter of authorization. Place of Performance or Delivery: The Period of Performance is: 09/28/2026 � 09/27/2027 Delivery within 30 days of award, or as otherwise mutually agreed to Place of Performance/Delivery: NIH Clinical Center in Bethesda, MD ------------------------------------------------------------------------------------------------------------------------------------------------------------ The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (SEPT 2023) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (DEC 2022) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements � Representation (JAN 2017) 52.204�26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (DEC 2022) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (SEP 2023) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm. ---------------------------------------------------------------------------------------------------------------------------------- By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. The government intends to award a �firm fixed price� order (in the form of a PO, IDIQ, or BPA) to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The government will evaluate quotes to determine the proposal that conforms to the solicitation and presents the best value to the government (eg. the most advantageous to the Government based on price, performance, availability of funds, etc.). The award will be made based on technical capability to meet the requirements/technical factors, price, and past performance. Submission shall be received not later than 09/28/2026 by @ 10:00 AM EST. Offers may be emailed to Lu Chang at <lu-chang.lu@nih.gov> by the date and time stated above. Late submission shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via email to the respective contacts above. Offers shall include RFQ number in the subject line (RFQ-26-008281). Offers shall also include the price, delivery timeframes, and any other required documentation/information as mentioned above. Offers that do not meet these requirements may be excl

Who won similar work

25 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same industry group (NAICS 3345).

Single-winner award sizes (25): middle half $37K to $230K, median $65K; range $14K to $5.9M.

WinnerAwardsValueLast
AGILENT TECHNOLOGIES INC · $A · $6.8B2$401KJul 24, 2025
GOVERNMENT SCIENTIFIC SOURCE INC2$283KDec 17, 2025
10X GENOMICS, INC. · $TXG · $618.7M2$77KSep 22, 2025
GE PRECISION HEALTHCARE LLC1$5.9MSep 17, 2025
FEI COMPANY1$1.8MSep 22, 2025
BRUKER BIOSPIN CORP · $BRKR · $3.0B1$1.4MSep 18, 2025
BECTON, DICKINSON AND COMPANY · $BDX · $19.4B1$1.3MJan 3, 2025
BRUKER NANO, INC · $BRKR · $3.0B1$230KAug 14, 2026
Sony Biotechnology Inc.1$227KAug 17, 2026
NEWPORT CORP1$212KJul 8, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $A reported $6.8B revenue in FY2025. The median single-winner award in these 25 past awards, $65K, is under 0.1% of that. 10-K
  • $TXG reported $618.7M revenue in FY2025. The median single-winner award in these 25 past awards, $65K, is under 0.1% of that. 10-K
  • $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 25 past awards, $65K, is under 0.1% of that. 10-K
  • $BDX reported $19.4B revenue in FY2025. The median single-winner award in these 25 past awards, $65K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 4 of the past winners are listed companies
  • 0 insider buys and 8 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.